A CRS grant to validate therapeutic targets in liver cancer
Published on October 31, 2023
The Board of Directors of the Cancer Research Society (CRS) recently approved 83 new operating grants in Canada, representing a total investment of $10.4 million.
The team led by Sylvain Meloche, Director of IRIC’s Signaling and Cell Growth Research Unit, has been awarded a two-year grant of $125,000 for the project “Advanced preclinical validation of SRC-family kinases as therapeutic targets in liver cancer”. This grant is funded in partnership with the Canadian Liver Foundation.
Congratulations to the whole team!